Cr. Huang et al., Adult Enterobacter meningitis: A high incidence of coinfection with other pathogens and frequent association with neurosurgical procedures, INFECTION, 29(2), 2001, pp. 75-79
Background: The clinical characteristics of Enterobacter infection in adult
bacterial meningitis were defined.
Patients and Methods: The clinical manifestations and therapeutic outcomes
of ten adult patients with Enterobacter infections in acute bacterial menin
gitis were analyzed.
Results: Enterobacter infection was found in 4.5% (10/223) of our adult pat
ients with culture-proven bacterial meningitis. The ten patients comprised
seven men and three women aged between 16-69 years (mean 47 years). Coinfec
tions with other pathogens were found in 50% of the cases, the most common
pathogen being Klebsiella pneumoniae. Nine of the ten patients had a histor
y of neurosurgery, and seven patients contracted the infection nosocomially
. Multiple antibiotic-resistant strains, including resistance to third-gene
ration cephalosporins, were found in three patients with polymicrobial infe
ctions. These three patients received iv imipenem/cilastin therapy. The the
rapeutic results showed that two of the ten patients died; five of the eigh
t surviving patients had neurological sequelae.
Conclusion: The predominant coinfection with Enterobacteriaceae in adult En
terobacter meningitis may reflect the fact that most of the cases of polymi
crobial Enterobacter infections have a potential gastrointestinal source. A
postneurosurgical state was the most important predisposing factor for the
development of Enterobacter infection in adult bacterial meningitis in our
patients, The strains of the Enterobacter species in adult polymicrobial E
nterobacter meningitis were commonly resistant to multiple antibiotics, inc
luding third-generation cephalosporins. In Light of the high incidence of m
ultiple antibiotic-resistant Enterobacter strains in adult polymicrobial En
terobacter meningitis, the choice of initial empiric antibiotics may includ
e carbapenem (imipenem/cilastin or meropenem). Although the mortality rate
was not high in this group of patients, most survivors suffered neurologica
l sequelae.